BioCardia, Inc.
General ticker "BCDA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.1M (TTM average)
BioCardia, Inc. does not follow the US Stock Market performance with the rate: -30.4%.
Estimated limits based on current volatility of 4.9%: low 0.85$, high 0.94$
Factors to consider:
- Earnings expected soon, date: nan
- Total employees count: 20 (-44.4%) as of 2023
- Top business risk factors: Operating losses, Capital shortage, FDA approval delays, Manufacturing limitations, Market competition
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.88$, 2.97$]
- 2026-12-31 to 2027-12-31 estimated range: [0.56$, 2.04$]
Financial Metrics affecting the BCDA estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: 24.07 < Shareholder equity ratio, % of 26.22 <= 33.49
Short-term BCDA quotes
Long-term BCDA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.48MM | $0.06MM | $0.00MM |
| Operating Expenses | $12.12MM | $8.06MM | $8.28MM |
| Operating Income | $-11.64MM | $-8.00MM | $-8.28MM |
| Non-Operating Income | $0.07MM | $0.06MM | $0.05MM |
| R&D Expense | $7.73MM | $4.39MM | $4.96MM |
| Income(Loss) | $-11.57MM | $-7.95MM | $-8.23MM |
| Net Income(Loss)* | $-11.57MM | $-7.95MM | $-8.23MM |
| Stockholders Equity | $-1.60MM | $0.84MM | $0.90MM |
| Assets | $2.99MM | $3.72MM | $3.41MM |
| Operating Cash Flow | $-9.97MM | $-7.89MM | $-7.44MM |
| Capital expenditure | $0.01MM | $0.01MM | $0.01MM |
| Investing Cash Flow | $-0.01MM | $-0.01MM | $-0.01MM |
| Financing Cash Flow | $3.73MM | $9.16MM | $7.57MM |
| Earnings Per Share** | $-8.19 | $-2.90 | $-1.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.